Properties of Steviolo Glycosides: Zero Calorie Sweetener
Edit
Stevia rebaudiana (Bert.) Bertoni, commonly called “sweet leaf” is a medicinally and industrially important plant known to be rich in zero calorie natural sweetening compound(s) known as ‘steviol glycosides’. The wide spectrum of pharmacological activities of steviol glycosides (SGs) have developed an interest among scientific & industrial communities to identify the potent pharmakoactive SGs. Therefore, several studies based on various biological activities and commercial applications of these natural sweeteners have been conducted and summarized.
sweet leaf stevioside stevia natural sweetener antidiabetic

1. Introduction

Stevia (family Asteraceae) is a perennial herb native to northern Paraguay. It was discovered by Moises Santiago Bertoni in 1877. Its leaves have traditionally been used by South American Guarani Indians due to their sweet taste and effectiveness in treating diabetes. Leaves of Stevia produce tetracyclic diterpene Steviol Glycosides (SGs), which are 200–300 times sweeter than table sugar [1]. Steviol glycosides, due to their complex structure, are not metabolised in the human body and are thus non-caloric [2]. Other bioactive compounds found in leaves include terpenoids (amyrin, limonene, kaurenoic acid, carvacrol), phenols (catechin, apigenin, chlorogenic acid, quercetin, trans-ferulic acid, cinnamic acid, leteolin-7-O-rutinoside), carbohydrates (L-arabinose, D-mannose, D-xylose, L-rhamnose), lipids (palmitic acid, stearic acid, linoleic acid), protein (serine), vitamins (ascorbic acid, niacin, riboflavin, thiamine) and minerals (calcium, magnesium, manganese, sodium, selenium, cobalt, phosphorus, zinc and potassium) [3][4][5]. Stevia extracts have hypotensive, hypoglycaemic, anti-inflammatory, and antimicrobial properties [6]. Studies have demonstrated that Stevia leaf extracts are hypoglycaemic [7], antimicrobial [8], antioxidant [9], antiviral [10], and anti-inflammatory [11]. With increasing rates of diabetes and obesity globally and the risks associated with artificial sweeteners, people are turning to natural sweeteners. As a result, Stevia-based sweeteners and medications are now available on the market and are in high demand. 
This entry provides information about the various applications of SGs in brief, however detailed information on other aspects of SGs including their biosynthesis and elicitation through biotechnological interventions.

2. Applications/Properties of SGs

2.1. Therapeutic

2.1.1. Antidiabetic Effect

Stevia is well known for its antidiabetic potential. Several reports have demonstrated the antihyperglycaemic effects of Stevia leaf extracts (aqueous, ether, ethanolic, and methanolic), purified steviol, stevioside, and rebaudioside A, in in vitro and in vivo models including human subjects [12][13][14][15][16][17][18][19][20]. Further, steviol glucuronide, isolated from human urine, showed dose and glucose-dependent stimulation of insulin secretion on mouse islets [18]. A number of studies have been carried out to understand the underlying mechanism of SG antidiabetic activity, and the following modes of action have been proposed: (i) enhancement of insulin secretion and sensitivity [12][13][14][19][21][22], (ii) glucose transport modulation [23] (iii) inhibition of glucagon secretion [12][21], (iv) upregulation of gene expression (PPAR-γ, GLUT4, GLUT 2, Gcgr) [14][15][16][18]. In a study proposed by Chen, Jeppesen, Nordentoft and Hermansen [14] and Bugliani, Tavarini, Grano, Tondi, Lacerenza, Giusti, Ronci, Maidecchi, Marchetti and Tesi [20], SGs protected mouse pancreatic beta cells from lipotoxicity and from the amelioration of glyburide-induced desensitization.
Stevioside, rebaudioside A, and steviol can potentially aid in the treatment of type 2 diabetes by increasing insulin production, lowering postprandial blood glucose, and protecting beta cells from damage.

2.1.2. Antihypertensive Effect

Many studies have revealed the effectiveness of stevioside in combating hypertension. Stevioside has been reported to reduce blood pressure (BP) in animals (rats and dogs) and humans [24][25][26][27][28][29]. When stevioside (95% purity) was administered intravenously to hypertensive rats, a marked reduction in BP was observed. Stevioside had a dose-dependent effect, with the maximum hypotensive activity at 200 mg/kg stevioside content [24]. Early reports have indicated that the hypotensive activity of stevioside is through a calcium antagonist mechanism (like verapamil) [30] and that its effect is prostaglandin activity-dependent [31], while other studies have shown the vasorelaxation activity of stevioside [24][32]. Further, studies on human patients have shown discrepancies in the effectiveness of stevioside [25][26][27]. Oral intake of capsules (500 mg stevioside) for two years showed a decrease in both systolic and diastolic blood pressure in mildly hypertensive patients as compared to placebo [26]. Other studies have reported that stevioside has no effect or a lower effect than other hypotensive drugs in human subjects [25][27]. GlucoMedix®, a suspension prepared from 15% volume/volume (v/v) of Uncaria bark extract and 11.67% weight/volume (w/v) of Stevia leaf extract powder (8.18% w/v SGs content), has been demonstrated to be safe and effective against hyperglycaemia, hyperlipidemia, and hypertension in rats [29]. Further, the safety and tolerability of stevioside allow it to be used as an alternative or supplementary therapy for hypertension [25][27].

2.1.3. Anticancer and Antitumor Effect

Many studies have been done to understand the activity and mechanisms mediating the anticancerous effects of SGs in both in vivo and in vitro models. Various SGs and their derivatives, like steviol, stevioside, rebaudioside A, steviolbioside, and isosteviol, have been explored to study their effect on cancer cell lines [33][34][35][36][37]. SGs are effective against cell lines and models of leukaemia, gastrointestinal cancer, lung cancer, cervical cancer, breast cancer, and prostate cancer [33][34][35][36][38]. Ref. [39] investigated the effects of Stevia extracts in a variety of solvents, including chloroform, acetone, water, ethanol, petroleum ether, and methanol, and assessed their potential cytotoxicity towards MCF-7 cell lines. All the extracts were effective, but petroleum ether produced the best results. In another in vitro study, Stevia leaf extracts in ethyl acetate and acetone exhibited more cytotoxicity on human laryngeal epithelioma cells in vitro [40]. Mechanistically, Stevia and its derivatives increase cytotoxicity, decrease cell viability, inhibit cell proliferation, arrest cells in the G1/G2 phase, and induce reactive oxygen-mediated apoptosis in different cell lines [33][34][35][36][38].To sum up, SGs are ideal candidates for cancer therapy or prevention since they exhibit anticancer activity and are less toxic to non-cancerous cells [41].

2.1.4. Antimicrobial Activity

Stevia extracts have been traditionally used in treating bacterial and fungal infections [32]. The antimicrobial activity of leaf extracts (aqueous, ethanol, ethyl acetate, acetone, methanol, chloroform, hexane, and acetone) has been investigated in several studies [3][40][42][43][44][45]. Bibi, Sarwar, Sabir, Nisa and Khan [42] evaluated the antimicrobial activity of Stevia leaf extracts (water and ethanol) against microorganisms including Aspergillus flavus (fungi), Staphylococcus aureus, Lactobacillus acidophilus (gram-positive bacteria), Salmonella typhi, and Escherichia coli (gram-negative bacteria). Ethanolic extract showed better antibacterial activity, while no antifungal activity was detected. In another study, antibacterial, antifungal, antiyeast, and antitumour activities were detected in leaf extracts (ethyl acetate, acetone, chloroform, and water) of Stevia [40]. These extracts can also be used against tooth decaying bacteria because they effectively inhibit the growth of cariogenic bacteria (16 strains of Streptococcus and Lactobacillus) [43].

2.2. Food/Other

Many sweeteners are available on the market, like aspartame, saccharin, and cyclamate [46]. But these sweeteners produce toxic substances inside the body that are often associated with many health risks [47][48]. Stevia has emerged as an alternative sweetener as it is reported to be safe for consumption [47][49]. Stevioside and rebaudioside A are the main sweetening substances in Stevia and account for 90% w/w of SGs in leaves [50]. Additionally, SGs are heat resistant, pH stable, and non-fermentative, with high solubility and stability in aqueous solutions [5].
Therefore, Stevia has become an indispensable part of food products and dietary supplements such as beverages, dairy products, bakery products, medicines, and many more [3][40][47][50][51][52][53]. A high-purity rebaudioside A sweetener, Rebiana, has been jointly commercialised by Cargill, Incorporation and The Coca-Cola Company; it has been successfully used in the preparation of food, beverages, confectionaries, nutraceuticals, and pharmaceuticals [54]. Some of the Stevia-based beverages with brand names such as Sprite Green, Zevia, Virgil Diet Soda, Virgil Zero, Virgil Coca, and Thomas Kemper Natural Diet Soda are also available on the market [55].

3. Toxicological studies

The safety of steviol glycosides for human consumption has been controversial assteviol glycosides have been associated with various acute, subacute, reproductive, andgenotoxicities [56]. The contradictory reviews on the safety of SG consumption publishedby Geuns [57] and Huxtable [58] led to clinical studies on the risk assessment of these naturalsweeteners, which confirmed their non-genotoxic and non-carcinogenic nature [59][60].Studies conducted in the early 1900s demonstrated that SGs pose no reproductive ordevelopmental hazards to animal subjects [61][62]. In the investigation of plasma profiles,metabolism, and excretion characteristics of intact and bile duct-cannulated rats,administered with radiolabelled rebaudioside A (reb-A), stevioside (stv), and steviol weredetermined. Many in vitro and in vivo studies have confirmed that SGs are neither digestednor absorbed by the upper gastrointestinal tract, thus making them safe for humanconsumption [63]. The United States Food and Drug Administration (USFDA) designatedStevia as generally recognised as safe (GRAS) in December 2008 [64], following whichthe Food Safety and Standards Authority of India (FSSAI) also lifted the ban on Stevia in2015. The European Food Safety Authority (EFSA) and the United States Food and DrugAdministration (USFDA) recommended high-purity leaf extracts of Stevia to be safe with anacceptable daily intake dose of 4 mg “steviol equivalents” per kilogram of body weight per day [65][66].

4. Conclusion

Based on the information provided above, it can be concluded that SGs are not only useful as zero calorie (natural) sweeteners, but can also be used as therapeutics for treatment of various metabolic disorders and chronic diseases. Moreover, its natural source of biosynthesis makes it even more useful for applications in both food and medicine without any worries for side-effects on the end users.

References

  1. Geuns, J.M.J.P. Stevioside. Phytochemistry 2003, 64, 913–921.
  2. Strauss, S.J.T.R. The perfect sweetener. Technol. Rev. 1995, 98, 18–20.
  3. Tadhani, M.B.; Subhash, R. In vitro antimicrobial activity of Stevia rebaudiana Bertoni leaves. Trop. J. Pharm. Res. 2006, 5, 557–560.
  4. Hossain, M.; Islam, M.; Islam, M.; Akhtar, S. Cultivation and uses of stevia (Stevia rebaudiana Bertoni): A review. Afr. J. Food Agric. Nutr. Dev. 2017, 17, 12745–12757.
  5. Schiatti-Sisó, I.P.; Quintana, S.E.; García-Zapateiro, L.A. Stevia (Stevia rebaudiana) as a common sugar substitute and its application in food matrices: An updated review. J. Food Sci. Technol. 2022, 1–10.
  6. Marcinek, K.; Krejpcio, Z. Stevia rebaudiana Bertoni: Health promoting properties and therapeutic applications. J. Consum. Prot. Food Saf. 2016, 11, 3–8.
  7. Anton, S.D.; Martin, C.K.; Han, H.; Coulon, S.; Cefalu, W.T.; Geiselman, P.; Williamson, D.A. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite 2010, 55, 37–43.
  8. Sunitha, V.; Wilsy, J.; Reginold, M. Antibacterial activity in medicinal plant (Stevia rebaudiana) using two solvents. Int. J. Rec. Scien. Res. 2015, 6, 5070–5071.
  9. Shukla, S.; Mehta, A.; Mehta, P.; Bajpai, V. Antioxidant ability and total phenolic content of aqueous leaf extract of Stevia rebaudiana Bert. Exp. Toxicol. Pathol. 2012, 64, 807–811.
  10. Kedik, S.; Yartsev, E.; Stanishevskaya, I. Antiviral activity of dried extract of Stevia. Pharm. Chem. J. 2009, 43, 198–199.
  11. Wang, T.; Guo, M.; Song, X.; Zhang, Z.; Jiang, H.; Wang, W.; Fu, Y.; Cao, Y.; Zhu, L.; Zhang, N. Stevioside plays an anti-inflammatory role by regulating the NF-κB and MAPK pathways in S. aureus-infected mouse mammary glands. Inflammation 2014, 37, 1837–1846.
  12. Jeppesen, P.B.; Gregersen, S.; Alstrup, K.; Hermansen, K.J.P. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: Studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine 2002, 9, 9–14.
  13. Abudula, R.; Jeppesen, P.B.; Rolfsen, S.E.D.; Xiao, J.; Hermansen, K. Rebaudioside A potently stimulates insulin secretion from isolated mouse islets: Studies on the dose-, glucose-, and calcium-dependency. Metabolism 2004, 53, 1378–1381.
  14. Chen, J.; Jeppesen, P.B.; Nordentoft, I.; Hermansen, K.J.M. Stevioside counteracts the glyburide-induced desensitization of the pancreatic beta-cell function in mice: Studies in vitro. Metabolism 2006, 55, 1674–1680.
  15. Assaei, R.; Mokarram, P.; Dastghaib, S.; Darbandi, S.; Darbandi, M.; Zal, F.; Akmali, M.; Omrani, G. Hypoglycemic effect of aquatic extract of Stevia in pancreas of diabetic rats: PPARγ-dependent regulation or antioxidant potential. Avicenna J. Med. Biotechnol. 2016, 8, 65.
  16. Bhasker, S.; Madhav, H.; Chinnamma, M.J.P. Molecular evidence of insulinomimetic property exhibited by steviol and stevioside in diabetes induced L6 and 3T3L1 cells. Phytomedicine 2015, 22, 1037–1044.
  17. Ahmad, U.; Ahmad, R. Anti diabetic property of aqueous extract of Stevia rebaudiana Bertoni leaves in Streptozotocin-induced diabetes in albino rats. BMC Complement. Altern. Med. 2018, 18, 179.
  18. Gu, W.; Rebsdorf, A.; Anker, C.; Gregersen, S.; Hermansen, K.; Geuns, J.M.; Jeppesen, P.B. Steviol glucuronide, a metabolite of steviol glycosides, potently stimulates insulin secretion from isolated mouse islets: Studies in vitro. Endocrinol. Diabetes Metab. 2019, 2, e00093.
  19. Abdel-Aal, R.A.; Abdel-Rahman, M.S.; Al Bayoumi, S.; Ali, L. Effect of stevia aqueous extract on the antidiabetic activity of saxagliptin in diabetic rats. J. Ethnopharmacol. 2021, 265, 113188.
  20. Bugliani, M.; Tavarini, S.; Grano, F.; Tondi, S.; Lacerenza, S.; Giusti, L.; Ronci, M.; Maidecchi, A.; Marchetti, P.; Tesi, M. Protective effects of Stevia rebaudiana extracts on beta cells in lipotoxic conditions. Acta Diabetol. 2022, 59, 113–126.
  21. Jeppesen, P.; Gregersen, S.; Rolfsen, S.; Jepsen, M.; Colombo, M.; Agger, A.; Xiao, J.; Kruhøffer, M.; Ørntoft, T.; Hermansen, K.J.M. Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism 2003, 52, 372–378.
  22. Gregersen, S.; Jeppesen, P.B.; Holst, J.J.; Hermansen, K.J.M. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 2004, 53, 73–76.
  23. Chowdhury, A.I.; Rahanur Alam, M.; Raihan, M.M.; Rahman, T.; Islam, S.; Halima, O. Effect of stevia leaves (Stevia rebaudiana Bertoni) on diabetes: A systematic review and meta-analysis of preclinical studies. Food Sci. Nutr. 2022, 10, 2868–2878.
  24. Chan, P.; Xu, D.-Y.; Liu, J.-C.; Chen, Y.-J.; Tomlinson, B.; Huang, W.-P.; Cheng, J.-T. The effect of stevioside on blood pressure and plasma catecholamines in spontaneously hypertensive rats. Life Sci. 1998, 63, 1679–1684.
  25. Chan, P.; Tomlinson, B.; Chen, Y.J.; Liu, J.C.; Hsieh, M.H.; Cheng, J.T. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br. J. Clin. Pharmacol. 2000, 50, 215–220.
  26. Hsieh, M.-H.; Chan, P.; Sue, Y.-M.; Liu, J.-C.; Liang, T.H.; Huang, T.-Y.; Tomlinson, B.; Chow, M.S.S.; Kao, P.-F.; Chen, Y.-J. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study. Clin. Ther. 2003, 25, 2797–2808.
  27. Ferri, L.J.; Alves-Do-Prado, W.; Yamada, S.S.; Gazola, S.; Batista, M.R.; Bazotte, R.B. Investigation of the antihypertensive effect of oral crude stevioside in patients with mild essential hypertension. Phytother. Res. 2006, 20, 732–736.
  28. Carrera-Lanestosa, A.; Acevedo-Fernandez, J.J.; Segura-Campos, M.R.; Velazquez-Martinez, R.; Moguel-Ordonez, Y. Antihypertensive, antihyperglycemic, and antioxidant effects of Stevia rebaudiana Bertoni (creole variety INIFAP C01) extracts on Wistar rats with induced metabolic syndrome. Nutr. Hosp. 2020, 37, 730–741.
  29. Villegas Vílchez, L.F.; Ascencios, J.H.; Dooley, T.P. GlucoMedix®, an extract of Stevia rebaudiana and Uncaria tomentosa, reduces hyperglycemia, hyperlipidemia, and hypertension in rat models without toxicity: A treatment for metabolic syndrome. BMC Complement. Med. Ther. 2022, 22, 62.
  30. Melis, M.; Sainati, A. Effect of calcium and verapamil on renal function of rats during treatment with stevioside. J. Ethnopharmacol. 1991, 33, 257–262.
  31. Melis, M.; Rocha, S.; Augusto, A. Steviol effect, a glycoside of Stevia rebaudiana, on glucose clearances in rats. Braz. J. Biol. 2009, 69, 371–374.
  32. Ruiz-Ruiz, J.C.; Moguel-Ordoñez, Y.B.; Segura-Campos, M.R. Biological activity of Stevia rebaudiana Bertoni and their relationship to health. Crit. Rev. Food Sci. Nutr. 2017, 57, 2680–2690.
  33. Toyoda, K.; Matsui, H.; Shoda, T.; Uneyama, C.; Takada, K.; Takahashi, M.J.F.; Toxicology, C. Assessment of the carcinogenicity of stevioside in F344 rats. Food Chem. Toxicol. 1997, 35, 597–603.
  34. Paul, S.; Sengupta, S.; Bandyopadhyay, T.; Bhattacharyya, A.J.N. Stevioside induced ROS-mediated apoptosis through mitochondrial pathway in human breast cancer cell line MCF-7. Nutr. Cancer 2012, 64, 1087–1094.
  35. Ukiya, M.; Sawada, S.; Kikuchi, T.; Kushi, Y.; Fukatsu, M.; Akihisa, T. Cytotoxic and apoptosis-inducing activities of steviol and isosteviol derivatives against human cancer cell lines. Chem. Biodivers. 2013, 10, 177–188.
  36. Gupta, E.; Kaushik, S.; Purwar, S.; Sharma, R.; Balapure, A.K.; Sundaram, S.J. Anticancer potential of steviol in MCF-7 human breast cancer cells. Pharmacogn. Mag. 2017, 13, 345.
  37. Chen, J.; Xia, Y.; Sui, X.; Peng, Q.; Zhang, T.; Li, J.; Zhang, J. Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively. Oncotarget 2018, 9, 26299.
  38. López, V.; Pérez, S.; Vinuesa, A.; Zorzetto, C.; Abian, O. Stevia rebaudiana ethanolic extract exerts better antioxidant properties and antiproliferative effects in tumour cells than its diterpene glycoside stevioside. Food Funct. 2016, 7, 2107–2113.
  39. Ibrahem, E.S.; Ragheb, E.M.; Yousef, F.M.; Abdel-Azizand, M.F.; Alghamdi, B.A. Nutritional Value, Cytotoxic and Antimicrobial Activities of Stevia rebaudiana Leaf Extracts. J. Biochem. Technol. 2020, 11, 108–115.
  40. Jayaraman, S.; Manoharan, M.S.; Illanchezian, S.J. In-vitro antimicrobial and antitumor activities of Stevia rebaudiana (Asteraceae) leaf extracts. Trop. J. Pharm. Res. 2008, 7, 1143–1149.
  41. Iatridis, N.; Kougioumtzi, A.; Vlataki, K.; Papadaki, S.; Magklara, A. Anti-Cancer Properties of Stevia rebaudiana; More than a Sweetener. Molecules 2022, 27, 1362.
  42. Bibi, S.; Sarwar, S.; Sabir, M.; Nisa, S.; Khan, T. Antimicrobial potential of Stevia rebaudiana leaves extract against selected bacterial and fungal strains. J. Adv. Nutr. Sci. Technol. 2021, 1, 157.
  43. Gamboa, F.; Chaves, M. Antimicrobial potential of extracts from Stevia rebaudiana leaves against bacteria of importance in dental caries. Acta Odontol Lat. 2012, 25, 171–175.
  44. Singh, S.; Garg, V.; Yadav, D.; Beg, M.N.; Sharma, N.; Sciences, P. In vitro antioxidative and antibacterial activities of various parts of Stevia rebaudiana (Bertoni). Int. J. Pharm. Pharm. Sci. 2012, 4, 468–473.
  45. Lemus-Mondaca, R.; Vega-Gálvez, A.; Rojas, P.; Stucken, K.; Delporte, C.; Valenzuela-Barra, G.; Jagus, R.J.; Agüero, M.V.; Pasten, A.J.; Plants, A. Antioxidant, antimicrobial and anti-inflammatory potential of Stevia rebaudiana leaves: Effect of different drying methods. J. Appl. Res. Med. Aromat. Plants 2018, 11, 37–46.
  46. Kant, R. Sweet proteins–potential replacement for artificial low calorie sweeteners. Nutr. J. 2005, 4, 5.
  47. Yadav, S.K.; Guleria, P.J. Steviol glycosides from Stevia: Biosynthesis pathway review and their application in foods and medicine. Crit. Rev. Food Sci. Nutr. 2012, 52, 988–998.
  48. Ribeiro, M.N.; Rodrigues, D.M.; Rocha, R.A.R.; Silveira, L.R.; Condino, J.P.F.; Júnior, A.C.; de Souza, V.R.; Nunes, C.A.; Pinheiro, A.C. Optimising a stevia mix by mixture design and napping: A case study with high protein plain yoghurt. Int. Dairy J. 2020, 110, 104802.
  49. Savita, S.; Sheela, K.; Sunanda, S.; Shankar, A.; Ramakrishna, P. Stevia rebaudiana–A functional component for food industry. J. Hum. Ecol. 2004, 15, 261–264.
  50. Gasmalla, M.A.A.; Yang, R.; Amadou, I.; Hua, X. Nutritional composition of Stevia rebaudiana Bertoni leaf: Effect of drying method. Trop. J. Pharm. Res. 2014, 13, 61–65.
  51. Goyal, S.K.; Samsher, N.; Goyal, R.K. Stevia (Stevia rebaudiana) a bio-sweetener: A review. Int. J. Food Sci. Nutr. 2010, 61, 1–10.
  52. Koyama, E.; Kitazawa, K.; Ohori, Y.; Izawa, O.; Kakegawa, K.; Fujino, A.; Ui, M. In vitro metabolism of the glycosidic sweeteners, stevia mixture and enzymatically modified stevia in human intestinal microflora. Food Chem. Toxicol. 2003, 41, 359–374.
  53. Putnik, P.; Bezuk, I.; Barba, F.J.; Lorenzo, J.M.; Polunić, I.; Bursać, D.K. Sugar reduction: Stevia rebaudiana Bertoni as a natural sweetener. In Agri-Food Industry Strategies for Healthy Diets and Sustainability; Academic Press: San Diego, CA, USA, 2020; pp. 123–152.
  54. Prakash, I.; DuBois, G.; Clos, J.; Wilkens, K.; Fosdick, L.J.F.; Toxicology, C. Development of rebiana, a natural, non-caloric sweetener. Food Chem. Toxicol. 2008, 46, S75–S82.
  55. Jain, P.; Kachhwaha, S.; Kothari, S.; Research, P. Biotechnology and metabolic engineering of Stevia rebaudiana (Bert.) Bertoni: Perspective and possibilities. Int. J. Life Sci. Biotechnol. Pharma Res. 2014, 3, 15.
  56. Geuns, J.M. Safety evaluation of Stevia and stevioside. Stud. Nat. Prod. Chem. 2002, 27, 299–319.
  57. Geuns, J.M. Safety of stevia and stevioside. Recent Res. Dev. Phytochem. 2000, 4, 75–88.
  58. Huxtable, R. Pharmacology and Toxicology of Stevioside, Rebaudioside A, and Steviol. Stevia: The Genus Stevia; Taylor and Francis: London, UK; New York, NY, USA, 2002.
  59. Koyama, E.; Kitazawa, K.; Ohori, Y.; Izawa, O.; Kakegawa, K.; Fujino, A.; Ui, M. In vitro metabolism of the glycosidic sweeteners, stevia mixture and enzymatically modified stevia in human intestinal microflora. Food Chem. Toxicol. 2003, 41, 359–374.
  60. Rajab, R.; Mohankumar, C.; Murugan, K.; Harish, M.; Mohanan, P. Purification and toxicity studies of stevioside from Stevia rebaudiana Bertoni. Toxicol. Int. 2009, 16, 49.
  61. Yodyingyuad, V.; Bunyawong, S. Effect of stevioside on growth and reproduction. Hum. Reprod. 1991, 6, 158–165.
  62. Mori, N.; Sakanoue, M.; Takeuchi, M.; Shimpo, K.; Tanabe, T. Effect of stevioside on fertility in rats [a sweet principle of Stevia rebaudiana bertoni, diet]. Shokuhin Eiseigaku Zasshi. J. Food Hyg. Soc. Jpn. 1981, 22, 409–414.
  63. Geuns, J.M.J.P. Stevioside. Phytochemistry 2003, 64, 913–921.
  64. Purkayastha, S.; Markosyan, A.; Prakash, I.; Bhusari, S.; Pugh, G., Jr.; Lynch, B.; Roberts, A. Steviol glycosides in purified stevia leaf extract sharing the same metabolic fate. Regul. Toxicol. Pharmacol. 2016, 77, 125–133.
  65. Additives, E.; Journal, N. Scientific opinion on the safety of steviol glycosides for the proposed uses as a food additive. EFSA J. 2010, 8, 1537.
  66. FAO; WHO. Evaluation of Certain Food Additives Eighty-Seventh Report of the Joint FAO/WHO Expert Committee on Food Additives; World Health Organization: Geneva, Switzerland, 2019; Volume 1020.
More
Information
Subjects: Plant Sciences
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : , , , , ,
View Times: 495
Revisions: 2 times (View History)
Update Date: 22 Feb 2023
Video Production Service